TENAX THERAPEUTICS, INC. (TENX) — real insider trading activity disclosed to the SEC, tracked automatically as new Form 4 filings are reported. Most recent: ADAR1 Capital Management, LLC — 5 open-market purchases between 2026-08-24 and 2026-09-03, totaling $3,174,265.
Transactions disclosed by company insiders to the SEC on Form 4, most recent first.
| Insider | Role | Date | Shares | Value |
|---|---|---|---|---|
| Doogan Declan | Insider | 2026-09-16 | 53,000 | $101,760 |
| Giordano Christopher Thomas | CEO | 2026-09-15 | 4,850 | $8,837 |
| Giordano Christopher Thomas | CEO | 2026-09-11 | 6,000 | $11,250 |
| STAAB THOMAS R II | Chief Financial Officer | 2026-09-11 | 5,675 | $10,981 |
| ADAR1 Capital Management, LLC | Insider | 2026-09-03 | 900,000 | $1,604,160 |
| ADAR1 Capital Management, LLC | Insider | 2026-09-02 | 187,704 | $337,586 |
| ADAR1 Capital Management, LLC | Insider | 2026-09-01 | 179,058 | $321,570 |
| ADAR1 Capital Management, LLC | Insider | 2026-08-31 | 403,571 | $722,594 |
| ADAR1 Capital Management, LLC | Insider | 2026-08-24 | 107,374 | $188,355 |
| ADAR1 Capital Management, LLC | Insider | 2026-08-21 | 716,369 | $1,266,254 |
Position changes disclosed in SEC Form 13F filings. These report a quarterly snapshot, not exact trade dates.
| Fund | Change | Quarter |
|---|---|---|
| Vivo Capital, LLC | Vivo Capital, LLC increased this position by 992% ($3,331,245 -> $36,375,000). | 2026-06-30 |
| FMR LLC | FMR LLC increased this position by 559% ($5,158,374 -> $33,992,598). | 2026-06-30 |
| Venrock Adviser, LLC | Venrock Adviser, LLC exited a position previously worth $26,787,439. | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | VANGUARD CAPITAL MANAGEMENT LLC increased this position by 296% ($4,212,102 -> $16,690,611). | 2026-06-30 |
| Candriam S.C.A. | Candriam S.C.A. opened a new position worth $10,896,012. | 2026-06-30 |
| BRAIDWELL LP | BRAIDWELL LP opened a new position worth $8,503,195. | 2026-06-30 |
| ARMISTICE CAPITAL, LLC | ARMISTICE CAPITAL, LLC exited a position previously worth $7,656,444. | 2026-06-30 |
| CITADEL ADVISORS LLC | CITADEL ADVISORS LLC increased this position by 430% ($1,725,385 -> $9,139,844). | 2026-06-30 |
Largest reported positions as of 2026-06-30.
| Fund | Value | Shares |
|---|---|---|
| Vivo Capital, LLC | $36,375,000 | 2,500,000 |
| FMR LLC | $33,992,598 | 2,336,261 |
| PERCEPTIVE ADVISORS LLC | $24,735,000 | 1,700,000 |
| VANGUARD CAPITAL MANAGEMENT LLC | $16,690,611 | 1,147,121 |
| MILLENNIUM MANAGEMENT LLC | $12,749,146 | 876,230 |
| Ikarian Capital, LLC | $11,459,580 | 787,600 |
| Candriam S.C.A. | $10,896,012 | 749,588 |
| RTW INVESTMENTS, LP | $10,135,094 | 696,570 |
| Stonepine Capital Management, LLC | $9,603,000 | 660,000 |
| CITADEL ADVISORS LLC | $9,139,844 | 628,168 |
Data compiled from public SEC filings. This is informational reporting, not investment advice.
ADAR1 Capital Management, LLC, a 10%+ owner of Tenax Therapeutics, Inc. (TENX), disclosed another open-market purchase of the company’s stock in a Form 4 filing. On September 3, 2026, the investment firm bought 900,000 shares at $1.78 apiece, a transaction worth $1,604,160.00. Following the purchase, ADAR1 holds 6,524,151 shares indirectly, through a trust or affiliated … Read more
ADAR1 Capital Management, LLC, a 10%+ owner of Tenax Therapeutics, Inc. (TENX), disclosed another open-market purchase of the small-cap biopharmaceutical company’s stock in a Form 4 filed with the SEC. On August 24, 2026, the investment firm bought 107,374 shares at $1.75 apiece, an outlay of $188,355.47 paid from its own funds rather than acquired … Read more